• If you are wondering whether Philip Morris International at around US$189.61 is still offering fair value after its strong run, this breakdown is designed to give you a clearer picture of what you might actually be paying for.
• The stock has logged returns of 10.9% over the last 7 days, 20.6% over the last 30 days, 18.3% year to date and 15.2% over the past year, which naturally raises questions about how much future upside or risk is now priced in.
• Recent coverage has focused on Philip Morris International as a mature tobacco company that investors often watch closely for its income profile and capital allocation decisions, especially when share prices move sharply in a short period. Evergreen interest in the stock keeps valuation methods, risk factors and company fundamentals in regular focus for many investors.
• On Simply Wall St's 6 point valuation checklist, Philip Morris International currently scores 1 out of 6. The sections that follow will compare different valuation approaches, then finish with a way to connect those numbers to a fuller view of the company.

Philip Morris International scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Philip Morris International Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model looks at the cash Philip Morris International is expected to generate in the future, then discounts those projected cash flows back to today to estimate what the business might be worth in dollars right now.

On this 2 Stage Free Cash Flow to Equity model, the company’s last twelve months free cash flow is reported at about $10.6b. Simply Wall St uses analyst estimates where available and then extrapolates further years. For Philip Morris International, the model uses an estimated free cash flow of $13.5b for 2025, then a series of projected cash flows through to 2035, which gradually rise from around $11.0b in 2026 to about $15.1b in 2035 before discounting.

When those future cash flows are discounted back to today, the model arrives at an estimated intrinsic value of about $161.45 per share. Compared to a current share price of around $189.61, this implies the stock is about 17.4% above the DCF estimate of fair value.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Philip Morris International may be overvalued by 17.4%. Discover 50 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Philip Morris International Price vs Earnings

P/E is often the go to yardstick for profitable companies, because it directly links what you pay for the stock to the earnings the company is already generating. It gives you a quick sense of how many dollars of price you are paying for one dollar of earnings.

What counts as a "normal" P/E depends on what investors are expecting from the company. Higher growth expectations or lower perceived risk can justify a higher P/E, while lower growth expectations or higher risk usually point to a lower P/E as being more reasonable.

Philip Morris International currently trades on a P/E of 26.71x. That sits above both the Tobacco industry average P/E of 12.64x and the peer average of 20.85x. Simply Wall St’s Fair Ratio for the stock is 26.90x, which is a proprietary estimate of what P/E might make sense after considering factors such as earnings growth, profit margins, industry, market cap and key risks.

This Fair Ratio can be more helpful than a simple peer or industry comparison, because it attempts to adjust for differences in quality, risk and growth between companies. With the current P/E of 26.71x sitting slightly below the Fair Ratio of 26.90x, the stock screens as mildly undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Philip Morris International Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are introduced here as a simple way for you to attach a clear story about Philip Morris International to the numbers you see. You can do this by linking your view on its smoke free shift, regulation and margins to a forecast for revenue, earnings and P/E, and then to a fair value that can be compared with the current price. These Narratives are available on Simply Wall St's Community page, update automatically when new news or earnings arrive, and range from a more bullish view that aligns with a fair value of about US$210 to a more cautious stance closer to US$153. This allows you to quickly see where your own view sits on that spectrum.

For Philip Morris International, however, we will make it really easy for you with previews of two leading Philip Morris International Narratives:

Both are built from the same underlying data, but they reach different conclusions about what the recent share price around US$189.61 might be pricing in. Use them as reference points to see which story is closest to your own view on smoke free growth, regulation and margins.

Fair value in this bullish narrative is set at US$192.60 per share.

On that basis, the current price is about 1.6% below this fair value estimate, so the stock screens as modestly undervalued in this scenario.

Implied revenue growth runs at about 6.52% a year, with profit margins and future P/E assumptions aligned to that higher growth profile.

• Analysts in this camp see smoke free products such as IQOS, ZYN and VEEV supporting higher revenue, stronger margins and a reduced regulatory burden over time, helped by adoption in a range of markets.
• They factor in earnings rising from US$11.1b today to about US$15.4b by 2029, with profit margins moving from 26.7% to 30.8% and the stock trading on a future P/E of 24.6x, above the 18.1x industry level cited for GB Tobacco.
• This view leans on continued investment in digital channels, geographic breadth and an expanding reduced risk portfolio. It also flags risks such as cigarette volume decline, illicit trade, tax changes, currency swings and the possibility that smoke free growth slows.

Fair value in this more cautious narrative is set at US$170.00 per share.

With the stock around US$189.61, that implies the price sits roughly 11.5% above this fair value estimate, so the shares look overvalued in this scenario.

Here, revenue growth is put at about 5.72% a year, with earnings and margins improving, but against tighter assumptions on future P/E and execution risks in next generation products.

• Analysts behind this narrative focus on public health sentiment, tougher regulation and ESG driven divestment as forces that could limit how much both cigarettes and newer products contribute to long term revenue and profit.
• They model revenues reaching US$47.1b and earnings of US$14.4b by 2028, with margins lifting from 21.0% to 30.7%, but with the stock valued on a lower future P/E of 20.6x compared with 32.8x today and below the 30.5x GB Tobacco industry figure cited here.
• This view assumes that ongoing declines in combustibles, illicit trade, regulatory complexity and heavy investment needs in IQOS, ZYN and VEEV could justify a discount to today’s multiples, even if the underlying business continues to improve.

Taken together, these two Narratives frame a fair value range from about US$170 on the cautious end to around US$192.60 for the more optimistic view, with community Narratives also stretching to targets closer to US$153 and US$210. The key step for you is to decide which set of assumptions on regulation, smoke free adoption, margins and valuation multiples you find more reasonable at today’s price, and then track how that view holds up as new data comes through.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Philip Morris International on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for Philip Morris International? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.